ISEE — IVERIC bio Share News
0.000.00%
Last trade - 00:00HealthcareAdventurousLarge Cap
Brief: Iveric Bio Announces Deal For Up To $250 Mln In Non-Dilutive Debt Financing With Hercules Capital And Silicon Valley Bank
Iveric Bio Inc Expected To Post A Loss Of 31 Cents A Share: Earnings Preview
Brief: Iveric Bio And Delsitech Enter Exclusive Agreement For Development Of Sustained Release Zimura
Brief: Iveric Bio - Agreed To Pay Delsitech Up To Eur35.0 Million If Co Achieves Specified Clinical, Development Milestones With Respect To Licensed Product
U.S. STOCKS ON THE MOVE-Boeing Co, Rambus Inc, Udemy Inc
U.S. STOCKS ON THE MOVE-Kellogg Co, Fastly Inc, CoreCard Corp
U.S. STOCKS ON THE MOVE-Qorvo Inc, Zoetis Inc, Fisker Inc
U.S. STOCKS ON THE MOVE-eBay Inc, Nikola Corp, Twitter Inc
Credit Suisse raises PT for Iveric Bio as eye therapy data expected sooner
Iveric Bio Inc reports results for the quarter ended in March - Earnings Summary
Brief: Iveric Bio Reports First Quarter 2022 Financial Results
Iveric Bio Inc expected to post a loss of 29 cents a share - Earnings Preview
Brief: Iveric Bio Reaffirmation Of Financial Guidance For FY22
Iveric Bio Inc reports results for the quarter ended in December - Earnings Summary
Brief: Iveric Bio Reports Fourth Quarter And Full Year 2021 Operational Highlights And Financial Results
Iveric Bio Inc expected to post a loss of 25 cents a share - Earnings Preview
Brief: Iveric Bio Announces Addition Of Christine Ann Miller, To Its Board Of Directors
Iveric Bio Inc reports results for the quarter ended in September - Earnings Summary
Brief: Iveric Bio Reports Third Quarter 2021 Financial Results